Clinical Trial

Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients

Study acronym: IMPORTANT
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to explore imaging, functional and systemic biomarkers of diabetic retinopathy (DR) progression, in Type 2 Diabetes (T2D) patients with moderate to severe non-proliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (PDR) using state of the art methodologies, commonly applied in clinical practice, over a period of two years. This study will provide longitudinal data to better understand retinal changes in moderate to severe diabetic retinopathy and early proliferative diabetic retinopathy and help guide timely interventions to prevent vision loss.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-05.
Trial Details
NCT Number NCT07458516
Lead Sponsor Association for Innovation and Biomedical Research on Light and Image
Collaborators: Fundação para a Ciência e a Tecnologia
Conditions Diabetic Retinopathy, Diabetes Mellitus, Type 2, Diabetic Complication, Retinal Disease
Enrollment 100 participants
Start Date 2025-11-24
Primary Completion 2027-12 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-11